The Effect of Home Care Planned According to Orem in Patients With Primary Brain Tumor and Their Caregivers
7. april 2022 oppdatert av: Derya Dağdelen, TC Erciyes University
The Effect of Planned Homecare According to Orem on the Self-care Agency and Care Burden in Patients With Primary Brain Tumors and Caregivers: A Randomized Controlled Trial
This study was conducted to evaluate the effect of home care planned according to Orem on self-care agency and care burden in brain tumor patients and their caregivers.
The study was performed with patients who underwent surgery for a brain tumor and their caregivers in the neurosurgery clinic of a tertiary hospital.
Ethical committee approval, institutional permission, patients and their caregiver verbal and written consent were obtained.
According to Orem's nursing theory, home care practice combining education, counseling and nursing care started with pre-operative education in the hospital for the patients and caregivers in the intervention group and continued at home with 5 home visits in a 6-month period.
Self-Care Agency Scale, MD Anderson Symptom Inventory Brain Tumor-Turkish Form and Caregiver Burden Scale were used as measurement tools in the study.The value of p<0.05 was accepted statistically significant in the data analyses.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
In this randomized controlled experimental study, it was aimed to determine the effect of home care planned according to Orem on self-care agency and care burden in brain tumor patients and their caregivers.
The study was performed with patients who underwent surgery for a brain tumor and their caregivers in the neurosurgery clinic of a tertiary hospital.
Ethical committee approval, institutional permission, patients and their caregiver verbal and written consent were obtained.
According to Orem's nursing theory, home care practice combining education, counseling and nursing care started with pre-operative education in the hospital for the patients and caregivers in the intervention group and continued at home with 5 home visits in a 6-month period.
Self-Care Agency Scale, MD Anderson Symptom Inventory Brain Tumor-Turkish Form and Caregiver Burden Scale were used as measurement tools in the study.
In addition, measurement tools used in patients and caregivers were applied to an average of 6 month: before surgery preoperative assessment at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
Data were analyzed with descriptive statistics, two-way analysis of variance.
Bonferroni correction was applied when comparing the main effects and comparisons between categorical variables and groups were evaluated with Fisher's exact test, p<.05 value was considered statistically significant.
Studietype
Intervensjonell
Registrering (Faktiske)
36
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Eyalet/Yerleşke
-
Kayseri, Eyalet/Yerleşke, Tyrkia, 38260
- Erciyes University Faculty of Health Science
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
inclusion criteria for patient;
- living within the borders of the region,
- being over 18 years old,
- being at least literate, being able to communicate in Turkish,
- being oriented to person, place and time, not having hearing and speaking problems,
- having primar brain tumor (glial or meningeal) surgery,
- taking part in grade I, II, III
- and having Karnovsky Performance Scale (KPS) score above 50 points.
exclusion criteria for patient;
- being under the age of 18,
- illiterate, unable to communicate in Turkish,
- being diagnosed with a neurological and psychiatric disorder that may affect the cognitive status,
- not being oriented to the person, place and time, having hearing and speaking problems,
- having surgery for a metastatic brain tumor,
- having surgery for a pituitary adenoma, to have undergone emergency surgery, to have a biopsy,
- to be in grade IV,
- to have a KPS score below 50 points.
Criteria for terminating the research process;
- wanting to leave the research process,
- meeting one of the criteria for exclusion from the sample after the surgery,
- spending the home care and follow-up process in another province, and/or not being able to reach the individual.
inclusion criteria for caregiver;
- being over the age of 18,
- being literate, being able to communicate in Turkish, and not having hearing and speaking problems,
- caring for a patient who had primary brain tumor surgery.
exclusion criteria for caregiver ;
- being under the age of 18,
- illiterate, unable to communicate in Turkish,
- being diagnosed with a neurological or psychiatric disorder that may affect the cognitive status,
- and having hearing and speech problems.
Criteria for terminating the research process;
- wanting to leave the research process,
- meeting one of the criteria for exclusion from the sample after the surgery,
- spending the home care and follow-up process in another province, and/or not being able to reach the individual.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Home care group
The home care program included education, counseling and nursing care to determine and meet the self-care/dependant care needs of patients and caregivers at home after brain surgery. At preoperative period (PRP) an average of 90-120 minutes of training was given to both the patient and the caregiver until the patient was discharged. At this stage, the training was carried out in order to prepare the patient and caregiver for the transition to home. At postoperative period (POP) two home visits were made within the first month following the discharge, planned for education, counseling and nursing care. The first home visit was made in the first week after discharge (10-18 days after surgery), and the second home visit was made 30-40 days after surgery. Then, in the home visits made once in the 2nd, 3rd and 4th months.No home visits were made between the 4th-month attempt and the 6th month, but telephone counseling was provided when necessary. Home visits ranged from 60 to 120 minutes. |
home care program
|
|
Ingen inngripen: Control group
The patient received routine care in the hospital until discharge.
Three home visits were made to collect the data of patients and caregivers in the 1st and 3rd and 6th months of POP after discharge, but no intervention was made.
The visits took about 30-45 minutes.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Self-Care Agency Scale (SCAS) Mean Score
Tidsramme: An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
SCAS: in order to evaluate the self-care agency of patients and caregiver each measurement was performed before the intervention at the time.
The lowest score is 35, the highest score is 140.
The highest score shows the greatest degree of self-care agency.Change= preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3).
and after surgery 6th month at home (Time 4).
|
An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
|
MD Anderson Symptom Inventory Brain Tumor-Turkish Form (MDA-BTSETr ) Mean Score
Tidsramme: An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
MDA-BTSETr: in order to evaluate the symptoms and the impact of the symptoms on the lives of patients, each measurement was performed before the intervention at the time.
The inventory consists of two parts that evaluate the symptoms and the interference of the individual's life.
In the first part of the inventory, individuals are asked to rate the severity of each symptom in the last 24 hours between 0-10 (0: no symptom, 10: the most severe level of the symptom experienced).
In the second part, individuals are asked to rate how much their symptoms interfere with their lives, from 0 to 10 (0: not interfered, 10: completely interfered).Change= preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3).
and after surgery 6th month at home (Time 4).
|
An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
|
Caregiver Burden Scale (CBS) Mean Score
Tidsramme: An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
CBS: in order to evaluate the care burden of individuals who care for patients who have undergone primary brain tumor surgery, each measurement was performed before the intervention at the time.
The lowest score that can be obtained from the scale is 0, the highest score is 88, and an increasing score indicates an increase in the burden of care.Change= preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3).
and after surgery 6th month at home (Time 4).
|
An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Karnofsky Performance Scale (KPS) Mean Score
Tidsramme: An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
KPS allows to determine the individual and medical care needs of the patient, to obtain information about symptom severity and level of function at work and home.
It is scored between 0-100.
The loss of function from normal function (100) to death (0) based on the functional status of the individual.
Change= preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3).
and after surgery 6th month at home (Time 4).
|
An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Derya Dağdelen, PhD, TC Erciyes Universty
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
6. mars 2019
Primær fullføring (Faktiske)
6. mars 2019
Studiet fullført (Faktiske)
30. juli 2020
Datoer for studieregistrering
Først innsendt
6. november 2021
Først innsendt som oppfylte QC-kriteriene
7. april 2022
Først lagt ut (Faktiske)
14. april 2022
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
14. april 2022
Siste oppdatering sendt inn som oppfylte QC-kriteriene
7. april 2022
Sist bekreftet
1. april 2022
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2019/179
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
produkt produsert i og eksportert fra USA
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .